pargyline has been researched along with Heart Diseases in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kleiner, Y | 1 |
Bar-Am, O | 1 |
Amit, T | 1 |
Berdichevski, A | 1 |
Liani, E | 1 |
Maor, G | 1 |
Reiter, I | 1 |
Youdim, MB | 1 |
Binah, O | 1 |
Gál, G | 2 |
Leszkovszky, G | 1 |
Lendvai, J | 1 |
Stanton, HC | 1 |
Schwartz, A | 1 |
Leszkovszky, GP | 1 |
4 other studies available for pargyline and Heart Diseases
Article | Year |
---|---|
TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Cardi | 2008 |
Quantitative evaluation of morphologic changes in experimentally induced myocardial necrosis.
Topics: Animals; Guanethidine; Heart Diseases; Iproniazid; Isoproterenol; Male; Monoamine Oxidase Inhibitors | 1966 |
Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
Topics: Animals; Blood Pressure; Body Weight; DNA; Female; Heart Diseases; Heart Rate; Hydrazines; Iproniazi | 1966 |
Observations on isoprenaline-induced myocardial necroses.
Topics: Animals; Guanethidine; Heart Diseases; Iproniazid; Isoproterenol; Male; Monoamine Oxidase Inhibitors | 1967 |